Harvia Oyj (HEL:HARVIA)

Theseus Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	45.2	46.45	40.58	25.31	15.49	27.32
Cash & Short-Term Investments	45.2	46.45	40.58	25.31	15.49	27.32
Cash Growth	-0.40%	14.46%	60.34%	63.42%	-43.31%	151.13%
Accounts Receivable	24.91	19.17	16.34	16.41	16.22	11.83
Other Receivables	0.66	2.74	6.42	1.97	4.25	2.66
Receivables	25.57	21.91	22.76	18.38	20.47	14.49
Inventory	52.96	49.15	35.48	45.32	46.13	20.7
Prepaid Expenses	-	0.09	0.15	1.31	0.09	0.17
Other Current Assets	0	0.9	0.43	-	-	0
Total Current Assets	123.73	118.5	99.39	90.32	82.18	62.67
Property, Plant & Equipment	35.17	36.27	29.39	29.24	30.64	19.59
Long-Term Investments	-	-	0.46	0.73	0.73	-
Goodwill	88.93	91.05	73.4	73.44	73.73	71.02
Other Intangible Assets	17.53	14.09	6.88	8.61	11.09	9.01
Long-Term Deferred Tax Assets	1.16	0.84	1.05	1.37	1.49	1.92
Long-Term Deferred Charges	-	1.33	1.34	1.28	1.02	1.01
Other Long-Term Assets	0.59	2.43	2.36	3.82	0.63	0.4
Total Assets	267.1	264.51	214.26	208.8	201.49	165.63
Accounts Payable	37.82	13.07	8.69	8.74	11.7	8.48
Accrued Expenses	0.16	11.41	7.99	8.95	9.79	6.97
Current Portion of Long-Term Debt	-	0.01	0.01	2.03	0.05	0.06
Current Portion of Leases	1.05	0.95	0.76	0.57	0.56	0.4
Current Income Taxes Payable	2.2	1.36	5.66	3.96	6.66	4.32
Other Current Liabilities	0.3	2.45	1.78	1.46	3.64	2.17
Total Current Liabilities	41.53	29.24	24.89	25.71	32.41	22.4
Long-Term Debt	95.42	95.4	75.4	75.39	56.86	57.23
Long-Term Leases	6.67	7.31	1.98	1.85	2.32	2.43
Long-Term Deferred Tax Liabilities	2.28	2.77	1.18	1.67	2.26	1.94
Other Long-Term Liabilities	3.39	3.94	0.48	3.94	20.9	9.92
Total Liabilities	151.04	140.43	105.61	110.45	117.34	96.77
Common Stock	0.08	0.08	0.08	0.08	0.08	0.08
Retained Earnings	85.58	86.83	75.08	63.77	47.89	23.73
Comprehensive Income & Other	29.2	35.94	32.41	33.43	32.59	42.63
Total Common Equity	114.86	122.84	107.58	97.27	80.55	66.44
Minority Interest	1.21	1.24	1.08	1.07	3.6	2.42
Shareholders' Equity	116.07	124.08	108.66	98.35	84.15	68.86
Total Liabilities & Equity	267.1	264.51	214.26	208.8	201.49	165.63
Total Debt	103.13	103.67	78.15	79.84	59.79	60.12
Net Cash (Debt)	-57.93	-57.22	-37.57	-54.53	-44.3	-32.79
Net Cash Per Share	-3.08	-3.04	-2.00	-2.89	-2.35	-1.74
Filing Date Shares Outstanding	19.06	18.68	18.69	18.67	18.64	18.64
Total Common Shares Outstanding	19.06	18.68	18.69	18.67	18.64	18.64
Working Capital	82.2	89.26	74.5	64.61	49.77	40.27
Book Value Per Share	6.03	6.58	5.76	5.21	4.32	3.56
Tangible Book Value	8.4	17.7	27.3	15.23	-4.27	-13.59
Tangible Book Value Per Share	0.44	0.95	1.46	0.82	-0.23	-0.73
Land	-	3.09	2.08	2.06	2.04	1.78
Buildings	-	31.07	29.89	29.47	27.64	22.83
Machinery	-	28.47	24.93	23.59	21.43	15.84
Construction In Progress	-	0.38	2.01	1.03	2.8	0.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.